Huntington's disease / edited by Thomas N. Chase, Nancy S. Wexler, André Barbeau.

Format:

Book

Contributor:

Chase, Thomas N. (Thomas Newell), 1932-

Wexler, Nancy S.

Barbeau, André.

Series:

Advances in neurology ; v. 23.

Advances in neurology ; v. 23

Language:

English

Subjects (All):

Huntington's disease--Congresses.

Huntington's disease.

Huntington Disease.

Medical Subjects:

Huntington Disease.

Genre:

Conference proceedings.

Electronic books.

Conference papers and proceedings.

Physical Description:

xxvii, 820 pages : illustrations ; 24 cm.

Place of Publication:

New York : Raven Press, 1979.

Contents:

Epidemiologic approach to Huntington's disease

Huntington's disease: mortality and morbidity data from outside the United States

Mortality from Huntington's disease in the United States

Genetic linkage

Huntington's disease: types, frequency, and progression

Genetic linkage in Huntington's disease

Distortion of mendelian segregation in Huntington's diseases

Huntington's chorea: current neuropathological status

Neuronal nuclear-cytoplasmic changes in Huntington's chorea: electron microscope investigations

Ultrastructure of the neostriatum in Huntington's and Parkinson's disease

Physiology of the basal ganglia

a brief overview

Topographical organization of neurons related to arm movement in the putamen

Motor unit control in Huntington's disease: a possible presymptomatic test

Diagnosis of Huntington's disease

Computed axial tomography in Huntington's disease and persons at-risk for Huntington's disease

Cognitive and affective aspects of Huntington's disease

Investigations of the memory disorders of patients with Huntington's disease

Encoding processes, learning, and recall in Huntington's disease

Subtle cognitive deficits as 15- and 20-year precursors of Huntington's disease

Neuropsychological profile of Huntington's disease: patients and those at risk

Perceptual-motor, cognitive, and emotional characteristics of persons at risk for Huntington's disease

Dementias of Huntington's and Parkinson's disease.

Psychiatric syndromes in Huntington's disease

Neuroendocrine changes in Huntington's disease

an overview

Levodopa and glucose influence on prolactin secretion in Huntington's disease

Disturbances in hypothalamic-pituitary hormonal dopaminergic regulation in Huntington's disease

Dopaminergic drugs on growth hormone and prolactin secretion in Huntington's disease

Search for the mutant protein in Huntington's disease and schizophrenia

Growth of Huntington's disease fibroblasts during their in vitro life-span

Two-dimensional analysis of radiolabeled proteins in cultured Huntington's disease fibroblasts

Huntington's disease firbroblasts: nutritional and protein glycosylatin studies

Membrane defects in Huntington's disease

Erythrocyte membrane alterations in Huntington's disease

Comparison of reconstituted membranes from normal individuals and those with Huntington's disease

Concanavalin A-induced lymphocyte capping in Huntington's disease

temporal immunogenetics, Huntington's disease, and multiple sclerosis

Huntington's disease, antineuronal antibodies, brain antigens, and receptors for IgG in human choroid plexus

Antibody-dependent cytotoxicity in Huntington's disease.

Update on the biochemistry of Huntington's chorea

Brain gangliosides in Huntington's disease

Platelet serotonin and platelet MAO activity in individuals with Huntington's disease

Dopamine in Huntington's disease: a study of postmortum brain tissue

Substance P: decrease in substantia nigra and globus pallidus in Huntington's disease

Role of substance P as a "transducer" for dopamine in model choreas

Alterations in postmortem brain angiotensin-converting enzyme activity and some neuropeptides in Huntingotn's disease

Studies of neurotransmitter enzymes in Huntington's chorea

Amino acids, peptides, and polyamines in cortical biopsies and ventricular fluid in patients with Huntinton's disease

Cerebrospinal fluid GABA levels in Huntington's disease, "at-risk" for Huntington's disease, and normal controls

Gamma-hydroxybutyrate: alterations in endogenous brain levels in Huntington's disease

Animal models of Huntington's disease

a review

Kainic acid neurotoxicity and Huntington's disease

Kainic acid neurotoxicity: insights into the pathophysiology of Huntington's disease

Excitotoxic amino acids and Huntington's disease

Catechol-O-methyltransferase in the kainic-acid treated rat striatum and in the basal ganglia in Huntington's disease

Effects of kainic acid on behavioral and biochemical aspects of cholinergic function.

Studies of kainate-induced caudate lesions in organotypic tissue culture

On mechanism of selective neuronal degeneration in the rat brain: studies with ibotenic acid

New animal model for Huntington's disease

Pharmacology of Huntington's disease

3H-dopamine binding studies in guinea pig striatal membrane suggesting two distinct dopamine receptor sites

Gamma-aminobutyric acid receptor binding curves for human brain regions: comparison of Huntington's disease and normal

Alterations in 3H-GABA binding in Huntington's disease: a phospholipid component?

Huntington's disease: alterations in neurotransmitter receptor binding in the human brain

Effects of GABA-mimetics on substantia nigra neurons

Measurement of GABA in biological fluids: effects of GABA transaminase inhibitors

Huntington's disease: overview of experimental therapeutics

Improvement in Huntington's disease with low dosages of dopaminergic agonists

Oral choline administration to patients with Huntington's disease

Treatment of Huntington's disease with alpha- and beta-adrenergic antagonists

Isoniazid therapy of Huntington's disease

Huntington's disease, INH, and prolactine levels.

Notes:

Includes bibliographical references and index.

Other Format:

Online version: Huntington's disease.

ISBN:

0890043744

9780890043745

OCLC:

5103103